Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis Oil for Chronic Non-Cancer Pain
NCT03635593Phase 2Unknown
- Sponsor
- Hamilton Health Sciences
- Start
- Jan 2019
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol, dronabinol in Chronic non-cancer pain (CNCP), sponsored by Hamilton Health Sciences. Status: unknown.
02
Drugs
cannabidioldronabinol
03
Conditions
Chronic non-cancer pain (CNCP)
Beyond the preview
Go deeper on NCT03635593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03635593.